The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks Hit By Failure Of Greek Talks

Mon, 15th Jun 2015 15:49

LONDON (Alliance News) - London stocks ended lower Monday, as equity markets across the world were hit by the the latest failure of talks between Greece and its creditors to deliver progress on "significant gaps" in reform plans for the cash-strapped country.

The FTSE 100 index ended down 1.1% at 6,710.52 points, while the FTSE 250 closed down 1.2% at 17,728.73. The AIM All-Share finished down 0.5% at 770.86.

Europe's major indices performed even worse, with the CAC 40 in Paris down 1.7% and the DAX 30 in Frankfurt down 1.8%.

When the European stock markets closed, Wall Street was lower with the DJIA down 0.7%, the S&P 500 down 0.6% and the Nasdaq Composite down 0.7%.

Greece's prime minister Monday urged the country's creditors to get "realistic", a day after weekend negotiations failed to bridge major differences, setting the stage for eurozone finance ministers to make a final push to reach a deal to avert a default.

Prime Minister Alexis Tsipras accused the institutions involved in the country's bailout negotiations of "political expediency" regarding their insistence on pension cuts. He said: "We do not have the right to bury European democracy at the place where it was born."

The European Central Bank joined Germany on Monday in insisting that the onus to resolve the Greek debt crisis now rests with Athens, as fears that Greece could eventually crash out of the eurozone triggered a new sell-off in equity markets.

"While all actors will now need to go the extra mile, the ball lies squarely in the camp of the Greek government to take the necessary steps," ECB President Mario Draghi told a hearing of the European Parliament in Brussels.

Draghi was echoing comments made earlier in the day by a spokesman for German Finance Minister Wolfgang Schaeuble.

"(The solution) now lies exclusively with Athens to respond to the generous offer made by the three institutions," the spokesman said, referring to the International Monetary Fund, the ECB and the European Commission.

He spoke after talks between cash-strapped Greece and its creditors collapsed on Sunday after the two sides once again failed to reach a deal to unlock the final EUR7.2 billion tranche of its bailout in exchange for Athens agreeing to a tough round of reform.

The comments came ahead of a crucial meeting of eurozone finance ministers on Thursday, where further talks on Greece's finances are to take place and just two weeks before an IMF debt repayment deadline and the expiry of the European part of the country's bailout.

"Draghi failed to clarify how much progress has been made on such a solution, likely because there hasn’t been any, whilst also refusing to speculate on the consequences of any potential Greek ECB repayment failures," said Spreadex analyst Connor Campbell.

Despite the deadlock in the talks, Athens insisted that it would meet its repayments.

"We believe there will be an agreement and there won't be any problem with repaying [the EUR1.6 billion the country owes to] the IMF at the end of June," Greek government spokesman Gabriel Sakellaridis said Monday. However, Sakellaridis went on to say that the Greek government has reached its limits on the counter-proposals it could submit.

"The Greek government submitted counter-proposals in order to cover the financing gap, as asked," he said.

In the US, investors are also cautious ahead of Wednesday's Federal Reserve interest rate decision. The Fed will also release a report including the Federal Open Market Committee's projection for inflation and economic growth over the next two years and a breakdown of individual FOMC member's interest rate forecasts.

In London, Standard Chartered was amongst the worst-performing stocks after Jefferies cut its price target on the bank to 656 pence from 722p, while keeping an Underperform recommendation. The broker said that incoming Chief Executive Bill Winters' need to improve capital ratios means the bank is likely to halve its dividend. Jefferies expects Standard Chartered's 2015 dividend per share to be 0.42p, down from 0.86p in 2014. Standard Chartered shares ended down 2.4% at 1,038.00p.

River and Mercantile Group Monday said it will manage a GBP700 million options mandate for the Royal Mail Pension Plan. The advisory and asset management business said it was appointed in April, with the structure of the mandate designed and executed in May. Royal Mail shares ended down 0.4% in the FTSE 100 while River and Mercantile, a main market stock not in a specific index, ended up 4.1%.

In the FTSE 250, NMC Health announced the acquisition of ProVita International Medical Center, a long-term medical care provider in the United Arab Emirates, for USD160.6 million in cash. NMC Health shares ended down 0.1%.

In the corporate calendar Tuesday, Whitbread issues a first quarter trading statement, Ashtead Group releases full year results and Crest Nicholson Holdings publishes half year results. Meanwhile, Record, Consort Medical, DJI Holdings and Trifast publish full year results. Servoca, Pressure Technologies release half year results, while Accsys Technologies issues a trading update.

In the economic calendar, the German consumer price index is due at 0700 BST. Meanwhile, UK consumer price index, retail price index and producer price indexes are due at 0930 BST. The German ZEW survey of economic sentiment is due at 1000 BST. In the US, housing starts data is due at 1330 BST, while the redbook index is due at 1355 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2017 08:10

Consort Medical splutters as BAT stubs out Voke programme

(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut

Read more
6 Dec 2016 08:18

Consort Medical posts good growth in first half

(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%

Read more
25 Nov 2016 09:07

Consort Medical appoints new CFO

(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive

Read more
27 Oct 2016 07:45

Consort Medical Welcomes Cimzia Autoclicks Launch On NHS

Read more
14 Oct 2016 12:23

Consort Medical's Bespak inks new agreement

(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat

Read more
19 Sep 2016 09:07

Consort Notes European Nod For Bespak Technology-Using Product

Read more
7 Sep 2016 08:43

Consort Medical signs agreement with AstraZeneca

(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be

Read more
7 Sep 2016 07:03

Consort Medical Sees Little Brexit Impact; Signs Deal With AstraZeneca

Read more
23 Jun 2016 15:19

Director dealings: Derwent London CEO sells just ahead of Brexit vote

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref

Read more
17 Jun 2016 09:29

Numis places Consort Medical 'under review'

(ShareCast News) - Consort Medical's shares were put 'under review' by Numis after the company reported its full year results. The pharmaceutical device frim on Thursday reported full year earnings before interest and tax rose 47.6% to £37m as revenues gained 49.8% to £276.9m, driven by a strong per

Read more
16 Jun 2016 14:52

Consort Medical's annual revenues rise as a product launch is delayed

(ShareCast News) - Consort Medical, a pharmaceutical device company, revealed higher full year profits on Thursday due to organic growth and an acquisition. Revenues rose 49.8% to £276.9m from £184.8m the previous financial year. Bespak, the company's drug device manufacturing subsidiary, continued

Read more
16 Jun 2016 07:37

Consort Medical Profit Doubles As Progress Made On DEV610 Programme

Read more
9 Jun 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
22 Feb 2016 16:51

Consort Medical agrees partnership and invests in Precision Ocular

(ShareCast News) - Consort Medical has made a £3.3m equity investment for a 13.7% stake in retinal therapeutics specialist Precision Ocular and agreed a development and manufacturing partnership. London-based Precision Ocular has developed retinal treatments that are designed to access specific sma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.